Anthera Announces Last Patient Enrolled in PEARL-SC Study - Sacramento Bee

Anthera Announces Last Patient Enrolled in PEARL-SC Study Sacramento Bee BAFF has been associated with a wide range of B-Cell mediated autoimmune diseases, including systemic lupus erythematosus, lupus nephritis, rheumatoid arthritis, multiple sclerosis, Sjogren's Syndrome, Graves' Disease and others. ... Anthera Announces Third Quarter 2011 Financial Report And Conference CallDaily Markets all 19 news articles »

Protalix BioTherapeutics to Present at Four Upcoming Conferences - MarketWatch (press release)

Protalix BioTherapeutics to Present at Four Upcoming Conferences MarketWatch (press release) ... also for the treatment of Gaucher disease; pr-antiTNF, a similar plant cell version of etanercept (Enbrel(TM)) for the treatment of certain immune diseases such as rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, ... and more »

Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ... - MarketWatch (press release)

Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ... MarketWatch (press release) Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis, epilepsy and other life-threatening diseases. Founded more than 20 years ago in ... Vertex Announces Presentation of New Data for Oral JAK3 Inhibitor VX-509 at ...SunHerald.com all 8 news articles »

Progenra and Tokyo Medical University Form Rheumatoid Arthritis Research ... - eYugoslavia.com

eYugoslavia.com

Progenra and Tokyo Medical University Form Rheumatoid Arthritis Research ... eYugoslavia.com Professor Nakajima discovered the Rheumatoid Arthritis (RA) biomarker and therapeutic target Synoviolin/Hrd1, a ubiquitin E3 ligase overexpressed in RA patients; it is believed Synoviolin inhibition will be therapeutically beneficial. ... Progenra and Tokyo Medical University Form Rheumatoid Arthritis Research ...MarketWatch (press release) all 9 news articles »